© 2024 Connecticut Public

FCC Public Inspection Files:
WEDH · WEDN · WEDW · WEDY
WECS · WEDW-FM · WNPR · WPKT · WRLI-FM · WVOF
Public Files Contact · ATSC 3.0 FAQ
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Connecticut's public health commissioner reminds doctors about anti-coronavirus medicines

Dr. Manisha Juthani answers a question from a journalist in July.
YEHYUN KIM
/
/ CTMIRROR.ORG
Dr. Manisha Juthani answers a question from a journalist.

With COVID-19 test positivity rates up significantly since their mid-March lows of around 2%, the Connecticut Department of Public Health is reminding physicians statewide about the availability and effectiveness of COVID-19 therapeutics. Those are medications that patients can take after testing positive to treat the illness.

For more on this, Department of Public Health Commissioner Dr. Manisha Juthani returned to “All Things Considered.”

Joining her on the program was Dr. Vivian Leung from the DPH team that oversees the distribution of the therapeutics.

John Henry Smith is Connecticut Public’s host of All Things Considered, its flagship afternoon news program. He's proud to be a part of the team that won a regional Emmy Award for The Vote: A Connecticut Conversation. In his 21st year as a professional broadcaster, he’s covered both news and sports.

Stand up for civility

This news story is funded in large part by Connecticut Public’s Members — listeners, viewers, and readers like you who value fact-based journalism and trustworthy information.

We hope their support inspires you to donate so that we can continue telling stories that inform, educate, and inspire you and your neighbors. As a community-supported public media service, Connecticut Public has relied on donor support for more than 50 years.

Your donation today will allow us to continue this work on your behalf. Give today at any amount and join the 50,000 members who are building a better—and more civil—Connecticut to live, work, and play.

Connecticut Public’s journalism is made possible, in part by funding from Jeffrey Hoffman and Robert Jaeger.